The main barrier in the progress of clinical gene therapy is the absence of a safe and efficient vector system with regulatable and tissue-specific characteristics. However, progress has been made in ...

The emerging field of RNA nanotechnology has led to the utilization of the platform in the field of bionanotechnology as sensing platforms, diverse nanoparticle construction, in vivo computing, and ...

The “outdated” downstream separation technologies used in viral vector manufacturing are a major cause of the industry’s struggles to keep up with growing demand from the gene therapy sector. At least ...